Explore more publications!

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on November 20, 2025

MEED Projects Awards in association with Mashreq 2025 MENA Winners Announced
Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
ELI: The Israel Association for Child Protection Earns 2025 Platinum Seal of Transparency from Candid
CHRISTUS Health recognized as ‘Most Wired’ health provider for digital transformation
BioSyent Releases Financial Results for Q3 and YTD 2025
BioSyent Declares Fourth Quarter 2025 Dividend
Regional Health Properties Reports Third Quarter 2025 Results Following Completion of Merger with SunLink Health Systems, Inc.
Equillium to Participate in Upcoming Investor Conferences
Information on the total number of voting rights and shares
Informations sur le nombre total de droits de vote et d'actions
انطلاق المؤتمر السابع عشر لجمعية القلب الخليجية بالدوحة 20 نوفمبر
Global AI business efficiency leader EFFY opens regional headquarters in Riyadh
The 17th Gulf Heart Association Conference
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Crinetics Announces First Patient Randomized in Pivotal Phase 3 CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome
Zevra Therapeutics, Inc. Announces CFO Transition
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions